It takes about 3000 genes to make a mitochondrion. Mitochondrial DNA encodes just 37 of these genes; the remaining genes are encoded in the cell nucleus and the resultant proteins are transported to the mitochondria. Only about 3% of the genes necessary to make a mitochondrion (100 of the 3000) are allocated for making ATP. More than 95% (2900 of 3000) are involved with other functions tied to the specialized duties of the differentiated cell in which it resides. Mitochondria contain the rate-limiting enzymes for pyrimidine biosynthesis (dihydroorotate dehydrogenase) and heme synthesis (d-amino levulinic acid synthetase) required to make hemoglobin. In the liver, mitochondria are specialized to detoxify ammonia in the urea cycle. Mitochondria are also required for cholesterol metabolism, for estrogen and testosterone synthesis, for neurotransmitter metabolism, and for free radical production and detoxification in addition to oxidizing the lipids, protein, and carbohydrates. Mitochondrial disease confirmation and establishment of a specific molecular diagnosis requires extensive clinical and laboratory evaluation. Dual genome origins of mitochondrial disease, multi-organ system manifestations, and an ever increasing spectrum of recognized phenotypes represent the main diagnostic challenges. To overcome these obstacles, compiling information from a variety of diagnostic laboratory modalities can often provide sufficient evidence to establish an etiology. These include blood and tissue histochemical and analyte measurements, neuroimaging, provocative testing, enzymatic assays of tissue samples and cultured cells, as well as DNA analysis.
INTRODUCTION
he mitochondria, as we know is the energy producing organelle in all except the red blood cells of the human body. All the chemical reactions that take place in the body are energy dependent, either directly or indirectly, and so is the involvement of the mitochondrion in them.
Hundreds of biochemical pathways consisting of many cycles and hundreds of enzymes are functioning in this ""power-house"" of the cell, as it is rightly called 1 . A mitochondrial disease is one that is caused basically due to defects at the molecular and genetic level which manifests as certain enzyme deficiencies or other related defects in the mitochondrial biochemical pathways. The mitochondrial DNA is mainly involved in these set of disorders. The two things that make a mitochondrial disease very unique are its inheritance pattern 2 and that fact that the mitochondrion is extremely critical to the various bodily functions. Weakness and much lesser energy production at the molecular level are generally accompanied by extreme variety of both, general and systemic clinical manifestations [3] [4] [5] [6] . This makes it extremely difficult for a clinician to diagnose the exact pathology the patient is presenting with, as most of the symptoms may be suggestive of various other systemic disorders. Certain common symptoms which may be typical for a mitochondrial disorder are lethargy, headache, vomiting and dizziness and in many cases even muscle weakness and ataxia. The degrees of the severity of a mitochondrial disease vary greatly [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Most of mitochondrial diseases are seen in pediatrics age group. This is because, any mitochondrial defect gives rise to the manifestations in the first few months or in some cases, even first few days of life. Some adult mitochondrial diseases are also found, and may be due to certain secondary complications, which is discussed in the following part of the article.
CLASSIFICATION OF MITOCHONDRIAL DISEASES
Following are the various major types of mitochondrial disorders 12, 15 , atherosclerotic disease and some cancers. For example, renal mitochondrial mutation and protein damage has been in observed in type 2 diabetes. Thus, mitochondrial damage also plays a role in diseases other than those who have their cause at the mitochondrial or nuclear genetic level.
CLINICAL MANIFESTATIONS AND BIOCHEMICAL FINDINGS
A large number of general and systemic symptoms are observed in most of the mitochondrial diseases 19 . In many mitochondrial diseases, the neuronal and muscular system is extensively affected 7 :  Ataxia . Also, epilepsy is observed in many of the cases along with a risk of status epilepticus 8 . Along with these, the renal 16 and hepatic systems are too involved in majority of the mitochondrial diseases in some way or the other. In fact, hepatopathies 35 . Besides this, the psychiatric presentations in the cases of mitochondrial disorders included mood disorder, cognitive deterioration, psychosis, and anxiety 32, [36] [37] [38] [39] .Thus, we can see that multi-organ pathologies and involvement of multiple, almost all systems of the body maybe indicative of a mitochondrial disorder.
The mitochondrial diseases, always present with some or the other peculiar biochemical findings 6, 20, 34, 35, 40 along with many common findings. For example, in the urea cycle disorders, hyperammonemia 1 is a characteristic feature. Be it any enzyme deficiency in the urea cycle, hyperammonemia will be present which can be used for a differential diagnosis for the urea cycle defects. Similarly, there will be hypoglycemia and increased levels or some enzyme specific dicarboxylic acids in the urine in most of the fatty acid β-oxidation disorders 1 . Hence, it is extremely important to carry out disease specific biochemical laboratory tests 40 to reach a definitive diagnosis.
GENETICS AND OCCURRENCE OF MITOCHONDRIAL DISEASE
Mitochondrial disease can be caused due to mutations in both nuclear and mitochondrial DNA. However, the mutations in the mitochondrial DNA are more frequently observed. Inheritance pattern in this case is purely maternal, fathers cannot pass on the defective mitochondrial genes to the offspring 2, 38 . Hundreds of mitochondrial mutations that cause a disease have been identified 41 . These are present on various loci of the circular mitochondrial DNA. For example, the Leber"s Hereditary Optic Neuropathy (LHON) 24 is due to a mutation in the gene ND1 on the mitochondrial DNA 1 is a diagnostic criteria applied to children referred for evaluation of mitochondrial disease in the US. It has certain parameters which are checked for in every case:
Molecular genetic testing can be carried out on genomic DNA extracted from blood (suspected nuclear DNA mutations and some mtDNA mutations), or on genomic DNA extracted from skeletal muscle (suspected mtDNA mutations). Southern blot is a molecular genetic testing technique used to detect a pathogenic mtDNA rearrangement. The deletion or duplication breakpoint may be mapped by mtDNA sequencing. The molecular diagnosis of mitochondrial diseases is generally based on Sanger sequencing and PCR-RFLP 38 .Muscle biopsies 43 are also done for the diagnosis in certain cases. Basically, the morphology of the mitochondria is checked for in the biopsies which can be taken from the muscle or any other tissue which is suspected to have a mitochondrial pathology. Also, some techniques like gas chromatography-mass spectroscopy 44 are being used for diagnostic purposes. Also, a brain MRI is used for detecting lactate peaks 45 . Thus, we can say that advancements have taken place in the diagnostics of the mitochondrial diseases in the past decade. MtSNP score is another diagnostic tool developed for the identification of the mitochondrial mutation 14 . 
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